Insurance typically covers GLP-1 medications prescribed for eligible conditions such as type 2 diabetes, obstructive sleep apnea, cardiac disease, vascular disease, kidney disease and stroke risk
Do not use if safety seal on cap is missing or broken
Cycle length is short: 4 to 6 weeks maximum
The GLP-1 startup making digital health look bad Plus: Color Health CEO Othman Laraki on healthcare superintelligence As a woman in my early 40s, I am a prime target for GLP-1 ads
Exenatide (Byetta, Bydureon) What It Is: Exenatide is a GLP-1 receptor agonist with both short-acting (Byetta) and long-acting (Bydureon) formulations available
In one Phase 3 trial, participants titrating up to the highest daily dose (36 mg) of Orforglipron lost about 10.5% of their initial body weight (~10.4 kg) after 72 weeks of treatment